Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4933
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression ; volume:17 ; number:1 ; day:9 ; month:3 ; year:2020 ; pages:1-14 ; date:12.2020
Immunity & ageing ; 17, Heft 1 (9.3.2020), 1-14, 12.2020
- Urheber
-
Bauer, Moisés E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12979-020-00178-w
- URN
-
urn:nbn:de:101:1-2020060405215709707870
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bauer, Moisés E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Clinical and subclinical neuropsychiatric abnormalities in rheumatoid arthritis patients
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Clinical and subclinical neuropsychiatric abnormalities in rheumatoid arthritis patients
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials